人工胸膜器官培养产生功能性iPSC衍生的CD4+不变性自然杀手T细胞
Sara Shiina1,2, Tatsuki Ueda1, Shoichi Iriguchi1,2
1Department of Cell Growth and Differentiation, Shin Kaneko Laboratory, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Communications biology
|January 9, 2026
概括
为癌症免疫疗法产生足够的不变天然杀手T (iNKT) 细胞是具有挑战性的. 三维有机体培养成功产生了CD4+单阳性iNKT细胞,证明了增强T细胞疗法的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 干细胞生物学 干细胞生物学
- 癌症治疗 癌症治疗
背景情况:
- 不变的自然杀手T (iNKT) 细胞通过激活免疫细胞具有抗瘤特性.
- 缺乏iNKT细胞 (淋巴细胞<0.1%) 阻碍了它们的治疗应用.
- 以前的二维培养可以产生双阴性iNKT细胞,但不能产生CD4+单阳性 (CD4SP) iNKT细胞.
研究的目的:
- 开发一种产生CD4SPiNKT细胞以增强抗瘤免疫力的方法.
- 描述从3D有机体培养中获得的iNKT细胞的功能能力.
主要方法:
- 利用三维 (3D) 器官培养技术,将iNKT细胞与诱导多能干细胞 (iPSC) 区分开来.
- 评估生成的iNKT细胞的表型和功能,包括增殖,细胞因子生产 (IFN-γ/IL-4) 和树突细胞成熟诱导.
- 评估了3D衍生的iNKT细胞逆转巨细胞诱导的免疫抑制的能力.
主要成果:
- 通过使用3D有机体培养成功生成了CD4SPiNKT细胞,称为3D-CD4+iNKT细胞.
- 这些3D-CD4+iNKT细胞表现出抗原特异性辅助功能,在用α-galactosylceramide刺激后增殖并产生IFN-γ/IL-4.
- 证明3D-CD4+iNKT细胞可以以抗原特异的方式诱导树突细胞成熟并逆转免疫抑制性巨细胞诱导的T细胞抑制.
结论:
- 三维有机体培养是一种有效的方法来产生功能性的CD4SPiNKT细胞.
- 3D-CD4+iNKT细胞作为辅助细胞来源有望增加现有的T细胞免疫疗法,用于固体瘤.
- 这种方法解决了iNKT细胞稀缺的挑战,为改进癌症治疗铺平了道路.
相关概念视频
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.